2167 Results for "

Fc

" in MedChemExpress (MCE) Product Catalog:
Products (2167)

2167 Results for "Fc" in MCE Product Catalog:

7
7 Publications Verification
Cat. No.: HY-B0005A
CAS No.: 89778-26-7
Synonyms: Z-Toremifene; NK 622 free base; Fc-1157a free base
Target:  

Estrogen Receptor/ERR

Domaines de recherche:  

Infection Cancer

Toremifene (Z-Toremifene) is a second-generation selective estrogen-receptor modulator (SERM) in development for the prevention of osteoporosis. Toremifene also potent inhibits infectious EBOV Zaire and Marburg (MARV) with IC50 of 0.07 µM and 2.6 µM, respectively .
7
7 Publications Verification
Cat. No.: HY-B0005
CAS No.: 89778-27-8
Synonyms: Z-Toremifene citrate; NK 622; Fc-1157a
Domaines de recherche:  

Infection Cancer

Toremifene citrate (Z-Toremifene citrate) is a second-generation selective estrogen-receptor modulator (SERM) in development for the prevention of osteoporosis. Toremifene citrate also potent inhibits infectious EBOV Zaire and Marburg (MARV) with IC50 of 0.07 μM and 2.6 μM, respectively .
7
7 Publications Verification
Cat. No.: HY-P70453B
Pureté:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Wnt3a Surrogate, Human (HEK293, Fc)
Species:  
Source:  
6
6 Cited Publications
Cat. No.: HY-N0762
CAS No.: 31524-62-6
Isobavachin is an orally active, blood-brain barrier-penetrating prenylated flavonoid present in Psoralea corylifolia. Isobavachin inhibits human CYP2B6, CYP2C9, CYP2C19, UGT1A1, UGT1A9, and UGT2B7. Isobavachin suppresses MAPK activation, NF-κB nuclear translocation, overexpression of iNOS/COX-2, FcεRI-mediated signaling pathways, and RANKL-induced osteoclastogenesis. Isobavachin induces autophagy, cytotoxicity, neuronal differentiation, and NRF2 activation; it alleviates oxidative damage, inflammatory responses, apoptosis, iron accumulation, mitochondrial biogenesis, and mast cell degranulation. Isobavachin is applicable to research related to liver injury, inflammatory diseases, osteoporosis, liver cancer, prostate cancer, glioma, periodontitis-induced bone loss, and Alzheimer's disease .
6
6 Cited Publications
Cat. No.: HY-P73388
Pureté:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: Tumor necrosis factor ligand superfamily member 11; RANKL; CD254; ODF; OPGL; TNFSF11; TRANCE
Species:  
Source:  
5
5 Cited Publications
Cat. No.: HY-13690
CAS No.: 53-19-0
Pureté:  99.92%
Synonyms: 2,4′-DDD; o,p'-DDD
Target:  

Apoptosis

Domaines de recherche:  

Cancer

Mitotane (2,4′-DDD), an isomer of DDD and derivative of dichlorodiphenyltrichloroethane (DDT), is an antineoplastic agent, can be used to research adrenocortical carcinoma. Mitotane exert its adrenocorticolytic effect at least in part through lipotoxicity induced by intracellular free cholesterol (FC) accumulation. Mitotane can have direct pituitary effects on corticotroph cells. Mitotane can induce CYP3A4 gene expression via steroid and xenobiotic receptor (SXR) activation, and has agent-agent interactions .
5
5 Cited Publications
Cat. No.: HY-P74133
Pureté:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Follicle-stimulating hormone; FSH; FSH alpha/beta
Species:  
Source:  
5
5 Cited Publications
Cat. No.: HY-P73104
Pureté:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: High mobility group protein B1; HMG-1; HMGB1; HMG1
Species:  
Source:  
4
4 Cited Publications
Cat. No.: HY-P99667
CAS No.: 1391727-24-4
Synonyms: OMP-54F28; FZD8-Fc

Target:  

Wnt

Domaines de recherche:  

Cancer

Ipafricept (OMP-54F28; FZD8-Fc) is a first class recombinant fusion protein with the extracellular part of the human frizzled-8 receptor fused to a human IgG1 Fc fragment that binds Wnt ligands, which blocks Wnt signaling. Ipafricept reduces tumor growth and results in a decrease in both liver and lung metastases combined with Gemcitabine (HY-17026) in pancreatic cancer mouse models. Ipafricept shows solid tumor inhibition activity with well tolerance, such as desmoid tumor, germ cell cancer, ovarian cancer .
4
4 Cited Publications
Cat. No.: HY-15322
CAS No.: 1370261-96-3
Pureté:  99.38%
Synonyms: P505-15; PRT-2607; BIIB-057
Target:  

Syk Apoptosis Caspase

Domaines de recherche:  

Inflammation/Immunology Cancer

PRT062607 (P505-15; PRT-2607) is an orally active ATP-competitive Syk inhibitor with an IC50 value of 1 nM, and exhibits at least 80-fold selectivity over other kinases. PRT062607 blocks B cell antigen receptor-mediated activation, Fcε receptor 1-mediated basophil degranulation and microglial phagocytosis, and induces caspase-dependent apoptosis and microglial death. PRT062607 inhibits tumor growth and peripheral nerve injury-induced mechanical allodynia, and prevents neuronal loss. PRT062607 can be used in research related to rheumatoid arthritis, chronic lymphocytic leukemia, non-Hodgkin's lymphoma, neurodegenerative diseases and neuropathic pain .
4
4 Cited Publications
Cat. No.: HY-P74379
Pureté:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: BMP-2B; BMP-4; Bone morphogenetic protein 4; DVR4
Species:  
Source:  
3
3 Cited Publications
Cat. No.: HY-B0723
CAS No.: 128607-22-7
Synonyms: Fc-1271a
Domaines de recherche:  

Neurological Disease Endocrinology Cancer

Ospemifene (FC-1271a) is an orally active and non-estrogenic selective estrogen receptor modulator (SERM) with Ki values of 380 and 410 nM for estrogen receptor α (ERα) and ERβ, respectively. Ospemifene inhibits caspase-3 activity. Ospemifene inhibits neuronal degeneration, prevents bone loss, and increases vaginal weight and vaginal epithelial height. Ospemifene has anticancer activity against breast cancer .
3
3 Cited Publications
Cat. No.: HY-P9977
CAS No.: 2171511-58-1
Synonyms: JNJ-61186372

Target:  

EGFR

Domaines de recherche:  

Inflammation/Immunology Cancer

Amivantamab (JNJ-61186372) is a human EGFR-MET bispecific antibody with immune anticancer activity. Amivantamab inhibits ligand binding, promotes endocytosis and degradation of receptor-antibody complexes, and induces Fc-dependent cytokinesis in macrophages and antibody-dependent cytotoxicity in natural killer cells .
3
3 Cited Publications
Cat. No.: HY-P72968
Pureté:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Dickkopf-related protein 1; Dickkopf-1; Dkk-1; SK; DKK1
Species:  
Source:  
3
3 Cited Publications
Cat. No.: HY-P73104A
Pureté:  ≥ 80%, as determined by reducing SDS-PAGE.
Synonyms: High mobility group protein B1; HMG-1; HMGB1; HMG1
Species:  
Source:  
3
3 Cited Publications
Cat. No.: HY-P73344
Pureté:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: CD279; hPD-1; PDCD1; Programmed cell death 1; SLEB2
Species:  
Source:  
3
3 Cited Publications
Cat. No.: HY-P99804
CAS No.: 2429913-18-6
Synonyms: MK1654

Target:  

RSV

Domaines de recherche:  

Infection

Clesrovimab (MK1654) is a humanized IgG1 monoclonal antibody targeting the respiratory syncytial virus (RSV) protein F. Clesrovimab binds to pre-fusion and post-fusion forms of RSV-A fusion protein with high affinity, with corresponding KD values of 71 pM and 480 pM, respectively. Clesrovimab is applicable for the research of RSV infection .
3
3 Cited Publications
Cat. No.: HY-P77587
Pureté:  ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: Calcitonin; CCP; PDN-21; CALCA; CALC1; CGRP; CGRP-I; CGRP1; CT; KC; PCT; Procalcitonin; Calcitonin 1; Katacalcin
Species:  
Source:  
3
3 Cited Publications
Cat. No.: HY-P77945
Pureté:  ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: GDF-15; MIC-1; NAG-1; PDF; PLAB; PTGFB; GDF15; MIC1; RG-1; Placental TGF-beta; PTGF-beta; PTGFBPTGF-beta
Species:  
Source:  
2
2 Cited Publications
Cat. No.: HY-141552
CAS No.: 2452401-65-7
Pureté:  99.61%
Domaines de recherche:  

Cardiovascular Disease

FC9402 is a potent and selective sulfide quinone oxidoreductase (SQOR) inhibitor extracted from patent WO 2020/146636 A1. FC9402 attenuates TAC-induced cardiomyocyte hypertrophy and left ventricle (LV) fibrosis. FC9402 can be used for cardiovascular regulation .